{
  "id": 3857500,
  "title": "Dolby VP, CAO and controller Ryan Nicholson sells $77,223 in stock",
  "url": "https://urgent.news/2026/08/28/dolby-vp-cao-and-controller-ryan-nicholson-sells-77-223-in-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-28T01:01:02.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/dolby-vp-cao-and-controller-ryan-nicholson-sells-77223-in-stock-93CH-4880401"
  },
  "original_language": "en",
  "account": "Dolby Laboratories' Chief Operating Officer, Corporate Controller, and Vice President, Ryan Nicholson, sold $77,223 worth of company shares on August 25, 2026. He exchanged 1,183 shares of Dolby Laboratories Class A Common Stock at $65.2773 per share. Currently, the stock price is $62.41, indicating potential upside for long-term investors based on InvestingPro analysis. According to the report, Dolby is included in their most undervalued stocks list. Following this stock sale, Nicholson directly owns 34,453 shares of Class A common stock, consisting of 19,303 shares of restricted stock units subject to forfeiture. Dolby's financials are impressive, boasting an 87.61% gross profit margin and a P/E ratio of 27.04. The company has consistently increased its dividend for 12 years, with a current yield of 2.31%. Dolby Laboratories recently reported mixed results for its fiscal third-quarter 2026, exceeding earnings expectations but falling short of revenue projections. Despite this, analysts remain optimistic about Dolby's prospects, particularly driven by upcoming deals.",
  "summary": null,
  "key_points": [
    "Ryan Nicholson sold $77,223 worth of Dolby shares on August 25, 2026",
    "Shares exchanged at $65.2773 per share, down from current $62.41 price",
    "Nicholson retains 34,453 Class A shares, including 19,303 restricted stock units"
  ],
  "editors_take": "The sale of $77,223 worth of shares by a high-ranking executive suggests potential concern about the company's near-term prospects despite analysts' optimism about upcoming deals and long-term growth.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}